Cite

    Yaochite, J. et al. (2016). Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties. Stem cell research & therapy. 7 (1), pp. 1-16. [Online].